Glaucocalyxin B induces apoptosis and autophagy in human cervical cancer cells
- Authors:
- Ying Pan
- Jieyu Bai
- Fangfang Shen
- Li Sun
- Quanzhong He
- Bing Su
-
View Affiliations
Affiliations: Xinxiang Key Lab of Translational Cancer Research, The Third Affiliated Hospital of Xinxiang Medical University, Xinxiang, Henan 453003, P.R. China
- Published online on: June 27, 2016 https://doi.org/10.3892/mmr.2016.5450
-
Pages:
1751-1755
Metrics:
Total
Views: 0 (Spandidos Publications: | PMC Statistics:
)
Metrics:
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics:
)
This article is mentioned in:
Abstract
Glaucocalyxin (Gln), an ent‑kaurane diterpenoid isolated from the Chinese traditional medicine, Rabdosia japonica, represents a novel class of anticancer drugs. GlnA is one of the three major forms of Gln and has demonstrated potent anticancer effects in a variety of cancer types. GlnB has only one structural difference from GlnA, an acetylated hydroxyl group at C14. This acetyl group results in high liposolubility and may enhance the antitumor activity of ent‑kaurane diterpenoid GlnB. However, few studies have reported the role of GlnB in cancer. The present study investigated the effect of GlnB in cervical cancer proliferation and cell death. Treatment with GlnB inhibits the proliferation of HeLa and SiHa cervical cancer cell lines in a dose‑dependent manner, as assessed by 3‑(4,5‑dimethylthiazol-2‑yl)-2,5 diphenyl tetrazolium bromide assays. In addition, GlnB increases the apoptotic cell population of HeLa and SiHa cells, as determined by fluorescence‑activated cell sorting analysis and enhanced poly (ADP‑ribose) polymerase 1 cleavage by western blotting. GlnB also induces increased light chain 3 II/I protein cleavage in both cells, indicating the induction of autophagy. Furthermore, GlnB treatment increased the expression of phosphatase and tensin homolog and decreased the expression of phosphorylated‑protein kinase B (Akt) in HeLa and SiHa cells, as assessed by western blotting. Taken together, the present results demonstrated that GlnB inhibited the proliferation of human cervical cancer cells in vitro through the induction of apoptosis and autophagy, which may be mediated by the phosphatidylinositol‑4,5‑bisphosphate 3‑kinase/Akt signaling pathway.
View References
|
1
|
Kim WK, Bang MH, Kim ES, Kang NE, Jung KC,
Cho HJ and Park JH: Quercetin decreases the expression of ErbB2 and
ErbB3 proteins in HT-29 human colon cancer cells. J Nutr Biochem.
16:155–162. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Rose PG, Bundy BN, Watkins EB, Thigpen JT,
Deppe G, Maiman MA, Clarke-Pearson DL and Insalaco S: Concurrent
cisplatin-based radiotherapy and chemotherapy for locally advanced
cervical cancer. N Engl J Med. 340:1144–1153. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Wieringa HW, van der Zee AG, de Vries EG
and van Vugt MA: Breaking the DNA damage response to improve
cervical cancer treatment. Cancer Treat Rev. 42:30–40. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Sun Y: The role of chinese medicine in
clinical oncology. Chin J Integr Med. 20:3–10. 2014. View Article : Google Scholar
|
|
5
|
Sun HD, Huang SX and Han QB: Diterpenoids
from isodon species and their biological activities. Nat Prod Rep.
23:673–698. 2006. View
Article : Google Scholar : PubMed/NCBI
|
|
6
|
Gao LW, Zhang J, Yang WH, Wang B and Wang
JW: Glaucocalyxin A induces apoptosis in human leukemia HL-60 cells
through mitochondria-mediated death pathway. Toxicol In Vitro.
25:51–63. 2011. View Article : Google Scholar
|
|
7
|
Xiao X, Cao W, Jiang X, Zhang W, Zhang Y,
Liu B, Cheng J, Huang H, Huo J and Zhang X: Glaucocalyxin A, a
negative Akt regulator, specifically induces apoptosis in human
brain glioblastoma U87MG cells. Acta Biochim Biophys Sin
(Shanghai). 45:946–952. 2013. View Article : Google Scholar
|
|
8
|
Han M, Li Z, Guo Y, Zhang J and Wang X: A
nanoparticulate drug-delivery system for Glaucocalyxin A:
Formulation, characterization, increased in vitro and vivo
antitumor activity. Drug Deliv. 1–7. 2015.
|
|
9
|
Demain AL and Vaishnav P: Natural products
for cancer chemotherapy. Microb Biotechnol. 4:687–699. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Gan P, Zhang L, Chen Y, Zhang Y, Zhang F,
Zhou X, Zhang X, Gao B, Zhen X, Zhang J and Zheng LT:
Anti-inflammatory effects of glaucocalyxin B in microglia cells. J
Pharmacol Sci. 128:35–46. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Yang WH, Zhang Z, Sima YH, Zhang J and
Wang JW: Glaucocalyxin A and B-induced cell death is related to GSH
perturbation in human leukemia HL-60 cells. Anticancer Agents Med
Chem. 13:1280–1290. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Kapoor V, Zaharieva MM, Das SN and Berger
MR: Erufosine simultaneously induces apoptosis and autophagy by
modulating the Akt-mTOR signaling pathway in oral squamous cell
carcinoma. Cancer letters. 319:39–48. 2012. View Article : Google Scholar
|
|
13
|
Le XF, Mao W, Lu Z, Carter BZ and Bast RC
Jr: Dasatinib induces autophagic cell death in human ovarian
cancer. Cancer. 116:4980–4990. 2010. View Article : Google Scholar : PubMed/NCBI
|
